ERT At-Home Cardiac Safety Assessment Ensures Trial Continuity

Applied Clinical Trials

Clinical site visits by patients may not be possible as healthcare providers focus their efforts on patients who require urgent care as a result of the COVID-19 pandemic. ERT has announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global ‘stay home’ mandates. The solution enables clinician-administered ECG readings, using ERT’s provisioned, FDA-cleared devices or other investigative site-owned equipment. 

To learn more, click here.